Who Paid My Doc
Fevipiprant
Drug
General payments
$3,194
Research payments
$6,430,495
Through program year 2020, $3,194 in general payments and $6,430,495 in research payments were reported against Fevipiprant.
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | General | $19 | 1 |
| 2020 | Research | $1,166,471 | 225 |
| 2019 | General | $3,175 | 99 |
| 2019 | Research | $5,264,024 | 296 |
Breakdown
Each share is of general payments naming this product in 2020.
Each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2020 where a state was reported.
Records
100 general · 521 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.